Daré Bioscience
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-18.17137.333.551.59
Price/Sales ratio
5.662.900.890.45
Earnings per Share (EPS)
$-0.11$0.01$0.58$1.29

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-46.52-21.58-0.14-0.60-0.28-0.89-1.47-3.19-2.26-0.95-0.00-0.28
Price/Sales ratio
13.57KN/A7.67N/AN/AN/AN/AN/A7.0110.230.00N/A
Price/Book Value ratio
23.9517.530.440.521.1328.97-35.013.156.31-5.697.431.13
Price/Cash Flow ratio
-56.96-26.77-0.17-2.75-0.74-0.95-1.59-4.25-3.88-0.73-2.12-0.95
Price/Free Cash Flow ratio
-56.30-26.54-0.17-2.75-0.74-0.95-1.59-4.24-3.86-0.72-2.12-0.95
Price/Earnings Growth ratio
-0.597.360.010.00-0.000.012.690.100.050.170.00-0.00
Dividend Yield
N/AN/AN/AN/AN/A6180.90%17.02%N/AN/AN/AN/A6180.90%
Profitability Indicator Ratios
Gross Profit Margin
100%N/A47.78%N/AN/AN/AN/AN/A99.52%98.63%N/AN/A
Operating Profit Margin
-25348.75%N/A-4850.39%N/AN/AN/AN/AN/A-313.85%-1098.33%-313.62%N/A
Pretax Profit Margin
-29177.49%N/A-5131.20%N/AN/AN/AN/AN/A-309.47%-1074.16%-309.24%N/A
Net Profit Margin
-29177.49%N/A-5131.20%N/AN/AN/AN/AN/A-309.47%-1074.16%-309.24%N/A
Effective Tax Rate
-4.63%-0.02%-0.21%62.31%-61.12%1.12%0.59%0.95%1414.48%N/AN/A-61.12%
Return on Assets
-43.71%-50.61%-104.29%-80.66%-344.56%-191.64%-362.88%-68.67%-70.61%-141.72%-70632.62%-191.64%
Return On Equity
-51.49%-81.23%-299.78%-86.53%-400.94%-3235.70%2379.08%-98.89%-278.50%597.53%-122151.55%-3235.70%
Return on Capital Employed
-44.73%-60.06%-179.06%-84.10%-250.61%-783.70%24936.30%-98.27%-257.20%-3846.43%-257272.01%-783.70%
Liquidity Ratios
Current Ratio
6.554.732.178.636.631.140.91N/AN/AN/A1.361.14
Quick Ratio
6.764.812.288.31375.72198.47242.72157.561.360.851.15198.47
Cash ratio
6.344.642.067.826.230.850.603.211.090.511.090.85
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A62.16123.380.06N/A
Days of Inventory outstanding
N/A-2.65K-1.67KN/A-60.23M-36.29M-15.64M-34.18MN/AN/AN/A-60.23M
Operating Cycle
N/AN/A-1.67KN/AN/AN/AN/AN/A62.16123.38N/AN/A
Days of Payables Outstanding
N/A4.23K1.31KN/A68.76K35.49K8.62K29.06K15.54K32.21KN/A35.49K
Cash Conversion Cycle
N/AN/A-2.99KN/AN/AN/AN/AN/A-15.48K-32.08KN/AN/A
Debt Ratios
Debt Ratio
0.050.250.34N/AN/AN/A0.04N/AN/AN/A0.74N/A
Debt Equity Ratio
0.060.410.97N/AN/AN/A-0.31N/AN/AN/A2.94N/A
Long-term Debt to Capitalization
N/A0.200.25N/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
0.060.290.49N/AN/AN/A-0.46N/AN/AN/A0.04N/A
Interest Coverage Ratio
-18.72-15.28-16.60-11.43N/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-6.10-1.57-2.61N/AN/AN/A-68.70N/AN/AN/A-79.55N/A
Company Equity Multiplier
1.171.602.871.071.1616.88-6.551.443.94-4.213.941.16
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-238.26N/A-43.78N/AN/AN/AN/AN/A-1.80-13.83-0.00N/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.0111.0011.001.001.001.011.001.00
Cash Flow Coverage Ratio
-6.10-1.57-2.61N/AN/AN/A-68.70N/AN/AN/A-79.55N/A
Short Term Coverage Ratio
-6.10-4.17-4.00N/AN/AN/A-68.70N/AN/AN/A-97.59N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A-5535.63%-25.04%N/AN/AN/AN/A-5535.63%